Language selection

Search

Patent 2092406 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2092406
(54) English Title: THERMOSTATICALLY-CONTROLLED MICROWAVE CYCLODESTRUCTION AS A TREATMENT FOR GLAUCOMA
(54) French Title: CYCLODESTRUCTION THERMOSTATEE PAR MICRO-ONDES UTILISEE POUR TRAITER LE GLAUCOME
Status: Expired and beyond the Period of Reversal
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61N 5/02 (2006.01)
  • A61B 18/18 (2006.01)
  • A61F 9/007 (2006.01)
(72) Inventors :
  • FINGER, PAUL T. (United States of America)
  • STERZER, FRED (United States of America)
(73) Owners :
  • MMTC INC.
  • NORTH SHORE UNIVERSITY HOSPITAL RESEARCH CORPORATION
(71) Applicants :
  • MMTC INC. (United States of America)
  • NORTH SHORE UNIVERSITY HOSPITAL RESEARCH CORPORATION (United States of America)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued: 2003-07-15
(86) PCT Filing Date: 1992-04-24
(87) Open to Public Inspection: 1992-11-12
Examination requested: 1999-04-20
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US1992/003425
(87) International Publication Number: WO 1992019414
(85) National Entry: 1993-03-24

(30) Application Priority Data:
Application No. Country/Territory Date
691,720 (United States of America) 1991-04-26

Abstracts

English Abstract


A miniaturized microwave applicator comprises a thin-wall metal dielectric-filled waveguide (200) having a thermocouple
(208) disposed in a groove (206) in the surface of the dielectric radiating aperture of the waveguide (200). When the aperture is
placed in contact with a spot on the outer surface of the sclera overlying the ciliary body to cyclodestruct by heat generated by
absorbed microwave energy radiated thereto during a given time, damage due to overheating of the scleral tissue is prevented by the
thermocouple (208), which monitors the sclera surface temperature, being used to thermostatically control the microwave energy
supplied to the waveguide in a manner that the scleral tissue temperature is maintained substantially constant at a value below
that which would cause damage thereto. The desired operation is dependent on the fact that very little of the microwave energy is
absorbed by the lower-water-content scleral tissue as it passes therethrough, but is highly absorbed by the underlying high
-water-content ciliary-body tissue.


Claims

Note: Claims are shown in the official language in which they were submitted.


7
CLAIMS:
1. A microwave applicator useful in the treatment of
glaucoma by cyclodestruction; said applicator comprising a
waveguide responsive to a microwave input of a given frequency
supplied thereto at its posterior end for radiating microwave
energy of said given frequency from the surface of an aperture
situated at its anterior end; wherein:
said waveguide includes a thin. metal wall filled with
solid dielectric material having a given dielectric constant
that extends between said anterior and posterior ends and has a
given area at said radiating aperture, whereby said radiating
aperture is a dielectric radiating aperture;
said surface of said dielectric radiating aperture
has a groove therein for housing a thermocouple;
said given dielectric constant of said solid
dielectric material has a value that approximates the value of
the dielectric constant of water; and
the size of said given area is sufficiently small to
permit said dielectric radiating aperture to contact only a
given spot of scleral tissue of an eye that overlies
substantially solely ciliary-body tissue of said eye.
2. The applicator defined in Claim 1, wherein:
said solid dielectric material consists of a ceramic
block having said given dielectric constant.
3. The applicator defined in Claim 1 or 2, wherein:
said given dielectric constant has a value of
substantially 85.
4. The applicator defined in Claim 1, 2 or 3, wherein:

8
said thin metal wall comprises a metal plating on the
surface of said ceramic block.
5. The applicator defined in any one of Claims 1 to 4,
wherein:
the size of said given area is substantially 0.03
square inch.
6. The applicator defined in any one of Claims 1 to 5,
wherein said microwave input is supplied to said posterior end
of said waveguide by transmission means exhibiting a
predetermined characteristic impedance; and wherein:
said thin metal wall filled with solid dielectric
material has a second given area of a certain size at the
posterior end of said waveguide, said certain size being such
as to provide said waveguide with an input impedance that
substantially matches said predetermined characteristic
impedance exhibited by said transmission means.
7. The applicator defined in Claim 6, wherein:
the size of said second given area is different from
that of said first-mentioned given area, and the cross section
area of said thin metal wall filled with solid dielectric
material tapers in size between said second and first-mentioned
given areas.
8. The applicator defined in Claim 7, wherein:
said first-mentioned given area has a width of
substantially 200 mil and a thickness of: substantially 150 mil;
and
said second given area has a width of substantially
200 mil and a thickness of substantially 100 mil.

9
9. The applicator defined in any one of claims 1 to
8, further comprising:
a thermocouple situated within the surface groove
in the dielectric radiating aperture; and
thermocouple output wires adapted to deliver a
signal indicative of the temperature of the thermocouple to
external means for thermostatically controlling the
microwave input supplied at the posterior end of the
waveguide in order to prevent the thermocouple temperature
from ever exceeding a temperature having a preselected value
that is below that which would result in damage to scleral
tissue,
whereby microwave energy radiated from the
dielectric aperture of the applicator may be used to effect
cyclodestruction by positioning the dielectric aperture in
contact with the given spot on the outer surface of scleral
tissue which overlies ciliary-body tissue, thereby also
situating the thermocouple in contact with the given spot.

Description

Note: Descriptions are shown in the official language in which they were submitted.


wo 92/19414 Pcr/uss2/0342~
~09~40~i
THERMOSTATICALLY-CONTROT T~FD MICROWAVE
CYCLODESTRUCIION
AS A TREATMENT FOR GLAUCOMA
BACKGROUND
As known in the art, several different cyclodestruction
10 procedures (i.e., procedures for destroying the ciliary body) have
been developed or proposed for treating glaucoma. The clinical
standard cyclodestruction procedure employs cryotherapy. Other
known cyclodestruction procedures include therapeutic
ultrasound and Neodymium:Yag cyclophotocoagulation. However,
15 all of these known cyclodestruction procedures have
demonstrated different negative tissue reactions.
Cryotherapy has been characterized by discomfort and
edema, therapeutic sound by induced scleral changes, and
Neodymium:Yag cyclophotocoagulation has been shown to cause
2 0 characteristic spot-like conjunctival lesions. Other less specific
morbidities have included corneal-scleral thinning, hyphema,
cataract, vitritis, retinal detachment, cystoid macula edema, and
hypotony. These potential complications have defined
cyclodestruction procedures as a last treatment for refractory
2 5 cases.
SUMMARY OF THE INVENTION
The present invention is directed to a microwave
3 0 cyclodestruction procedure which avoids negative tissue reactions
and minimi7es potential complications. The microwaves are
applied to the ciliary body by a novel miniature microwave
applicator placed in contact with a spot on the outer surface of the
sclera. The miniature microwave applicator incorporates a
3 5 thermocouple on its anterior radiating surface, so that the
thermocouple also contacts the spot on the outer surface of the
sclera. The thermocouple thermostatically controls the output of
SUBSTITUTE SH~ET

wo 92/19414 Pcr/uss2/o3425
~ g~0~~ 2
the microwave generator energizing the applicator to ensure that
the temperature of the scleral tissue never rises to an unsafe
level. Because scleral tissue absorbs less microwave energy, while
ciliary-body tissue absorbs more microwave energy, most of the
5 applied applied microwave energy penetrates through the sclera
to, and is absorbed by, the underlying ciliary body. This raises the
temperature of the ciliary body to the point at which some
cyclodestruction occurs. This process may be repeated at several
separate spots of the sclera to complete the microwave
l 0 cyclodestruction procedure.
BRIEF DESCRIPTION OF THE DRAVVINGS
FIGURE 1 is a functional block diagram showing the
l 5 relationship between a miniature microwave applicator
incorporating a thermocouple (which may take the form shown in
FIGURE 2) and a thermostatically-controlled microwave generator
for energizing the applicator;
FIGURE 2 illustrates the physical form of a preferred
2 0 embodiment of the miniature microwave applicator incorporating
a thermocouple that is used for microwave cyclodestruction;
FIGURE 3 is a first chart useful in explaining the principles
of the present invention; and
FIGURE 4 is a second chart useful in explaining the
2 5 principles of the present invention.
DESCRIPIION OF THE PREFERRED EMBODIMENT
Referring to FIGURE l, the microwave output of
3 0 thermostatically-controlled microwave generator 100 is applied as
an input to miniature microwave applicator incorporating a
thermocouple 102 (which may take the form shown in FIGURE 2)
over a suitable microwave transmission line 104. The
thermocouple of applicator 102 generates a control signal having a
3 5 value which is a function of the temperature at the microwave
radiating aperture of applicator 102. This control signal, which is
fed back to microwave generator 100 over connection 106 to
SJBSTITUTE SHEET

wo 92/19414 pcr/uss2/o342~
3 ~09~40~
thermostatically control microwave generator 100, prevents
microwave energy from being forwarded from the output of
microwave generator 100 over transmission line 104 to the input
of applicator 102 whenever the temperature of the thermocouple
5 rises to a certain preselected temperature.
Referring to FIGURE 2, applicator 102 comprises thin-wall
metal dielectric-filled waveguide.200. In practice, waveguide 200
is fabricated from a block of ceramic material that exhibits a high
dielectric constant (e.g., 85) that is machined to the proper size
1 0 and shape. The longitudinal surface of this properly sized and
shaped ceramic material is first electrolessly plated with metal
and then electroplated with metal to produce the thin metal wall
of waveguide 200. More specifically, the length of waveguide 200
is preferably about one inch; the width of waveguide 200 is
1 5 preferably about 0.2 inch (i.e., 200 mils); and the thickness of
waveguide 200 preferably tapers from about 0.1 inch (i.e., 100
mils) at at its posterior end, to which microwave input connector
202 is attached, to about 0.15 inch (i.e., 150 mils) at its anterior
end, which forms dielectric radiating aperture 204. Thus, the area
2 0 of dielectric radiating aperture 204 is quite small, being only 0.03
square lnch.
As shown in FIGURE 2, the dielectric anterior surface, which
is preferably flat, has a groove 206 machined therein in which
thermocouple 208 is fixedly secured substantially at the center
2 5 thereof. The thickness of the thermocouple is preferably sufficient
to protrude very slightly from the flat dielectric anterior surface.
Thermocouple output wires 210, connected to thermocouple 208,
extend through the length of groove 206 to the outside of
waveguide 200, as shown in FIGURE 2. Thermocouple output wires
30 210 constitute feedback connection 106 of FIGURE 1.
The therapeutic purpose of applicator 102 in the treatment
of glaucoma is to apply sufficient microwave energy to the ciliary
body to effect cyclodestruction without creating collateral eye
damage. This is accomplished by first positioning 0.03 square inch
3 5 dielectric radiating aperture 204 in contact with the anterior
surface of applicator 102 in contact with a 0.03 square inch spot
on the outer surface of the sclera which overlies the ciliary body
SUBSTITUTE ~tlEF~

wo 92/19414 Pcr/uss2/o342~
2092406
(e.g., a spot displaced about 2 millimeters beyond the outer edge
of the iris). This inherently places thermocouple 208 in in contact
with this spot. The applicator is energized with microwave energy
having a frequency (e.g. 5,000 to 6,000 MHz) which readily
5 penetrates the thickness of the scleral tissue with little absorption
and reaches a corresponding spot of the underlying ciliary body,
where it is readily absorbed. The reason for this is shown by the
FIGURE 3 chart, which will be discussed below.
The microwave energy is applied to the spot for a given
l 0 time (e.g., one minute) which is a sufficient time for the irradiated
spot of the ciliary body to be heated to a high enough temperature
to cause cyclodestruction, while the sclera itself is never heated
enough to raise its temperature sufficiently high to result in
damage thereto. (The FIGURE 4 chart, discussed in more detail
l 5 below, indicates the the relationship between temperature and
time of heating duration that results in damage to different types
of m~mm~lian tissue.) In any event, the thermostatic control of
microwave generator lO0 is set so that the radiated microwave
energy is cut off whenever the temperature of thermocouple 208
2 0 rises to a preselected therapeutic temperature which is below the
temperature at which scleral damage occurs. Thus, the continuous
monitoring of sclera-spot surface temperature by thermocouple
208 maintains the temperature substantially constant at the
therapeutic temperature and also ensures that the operation is
2 5 fail-safe.
In order to complete the microwave cyclodestruction
procedure, the above-described process is applied sequentially to
each of several (e.g., five) displaced spots on the outer surface of
the sclera. More specifically, after the above-described process
3 0 with respect to one of the several displaced spots is completed,
the applicator is displaced by about the width of applicator 102
(200 mils) to another similar scleral spot overlying the ciliary
body. Thus, the resulting several displaced spots tend to lie on the
circumference of a circle having a radius about 2 millimeters
3 5 larger than that of the iris.
Referring to the FIGURE 3 chart, there is shown the
penetration depth as a function of frequency at which l /e (where
~UBSTîTlJTE SHEET

wo 92/19414 Pcr/uss2/o3425
5 2~g2~0~
e is the base of natural logarithm) of incident microwave energy is
absorbed by low-water-content human tissue and by high-water-
content human tissue, respectively. It is apparent from this chart
that low-water-content human tissue is much more microwave
5 absorbent than high-water-content human tissue. Scleral human
tissue is low-water-content human tissue and ciliary-body tissue
is high-water-content human tissue. Thus, most of the applied
microwave energy merely passes through the thickness of the
scleral tissue to be then highly absorbed by the underlying
1 0 ciliary-body tissue, thereby preferentially heating the underlying
ciliary-body tissue.
Referring to the FIGURE 4 chart, there is shown
temperature- time duration thresholds for damage to occur in
different types of mammalian tissue. As indicated by the wide
1 5 band of the FIGURE 4 chart, for a given heating duration some
types of tissue (e.g., corneal tissue) are damaged substantially less
than others. It has been found that both corneal and scleral tissue
are not damaged by, and tolerate well, being heated to a
temperature up to about 50~ C for at least one minute. Therefore,
2 0 the aforesaid fail-safe thermostatically-controlled therapeutic
temperature for a heating duration of scleral tissue for one minute
certainly may be set at 50~ C, and perhaps even somewhat higher.
Returning to FIGURE 2, the high dielectric constant of the
dielectric filling of waveguide 200 of applicator 102 serves two
2 5 important purposes. First, by reducing the microwave wavelength
traveling therein for a given microwave frequency, the size of
applicator 102 for transporting that given microwave frequency
may be reduced (i.e., miniaturized). Second, the high dielectric
constant of the dielectric filling of waveguide 200 more nearly
3 0 matches the high dielectric constant of the high-water content
ciliary body, and, therefore, enhances microwave power transfer
from dielectric radiating aperture 204 to the ciliary body. Further,
for microwave power transfer purposes, the impedance at the
microwave input to applicator 102 at the posterior end of
3 5 waveguide 200 should closely match that presented by
transmission line 104, and the impedance at the microwave
output from applicator 102 at dielectric radiating aperture 204
SUBSTITUTE SHEET

wo 92/19414 pcr/~lss2/o342s
209240~ 6
(located at the anterior end of waveguide 200) should closely
match that presented by the scleral tissue with which it is in
contact. The proper impedance matching at both the posterior and
anterior ends of waveguide 200 is achieved by the above-
discussed tapering of the thickness of waveguide 200 from 100
mils at its posterior end to 150 mils at its anterior end.
The above-described controlled microwave cyclodestruction
procedure has been tested experimentally in the treatment of
induced glaucoma in the eyes of rabbits. Microwave induced
cyclodestruction was successful in reducing the intraocular
pressure in all treated glaucomatous eyes for a 4 week duration.
Two additional glaucomatous eyes were left untreated, served as
controls, and were noted to have persistently elevated intraocular
pressures. Then 6 additional eyes were subjected to an equivalent
treatment (50~C x 1 min. x 5 applications) which resulted in
approximately 180~ of heat treatment just posterior to the
corneal-scleral limbus. These specimens were evaluated by light
microscopy at time 0, 24 hours, and at 7 days after treatment.
Clinical and histopathologic evaluations suggested that
2 0 microwave thermotherapy (delivered under thermometry control)
allowed for chorioretinal/ciliary body destruction which resulted
in reductions of intraocular pressure in glaucomatous eyes.
SuBsTlTuTE S~

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Time Limit for Reversal Expired 2006-04-24
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Letter Sent 2005-04-25
Grant by Issuance 2003-07-15
Inactive: Cover page published 2003-07-14
Pre-grant 2003-04-25
Inactive: Final fee received 2003-04-25
Notice of Allowance is Issued 2002-10-25
Letter Sent 2002-10-25
Notice of Allowance is Issued 2002-10-25
Inactive: Approved for allowance (AFA) 2002-10-02
Letter Sent 2002-09-20
Reinstatement Requirements Deemed Compliant for All Abandonment Reasons 2002-09-11
Amendment Received - Voluntary Amendment 2002-09-11
Reinstatement Request Received 2002-09-11
Inactive: Abandoned - No reply to s.30(2) Rules requisition 2002-07-05
Inactive: Entity size changed 2002-05-07
Inactive: S.30(2) Rules - Examiner requisition 2002-03-05
Amendment Received - Voluntary Amendment 2002-01-04
Inactive: S.30(2) Rules - Examiner requisition 2001-09-05
Amendment Received - Voluntary Amendment 2001-07-13
Amendment Received - Voluntary Amendment 2001-06-15
Inactive: S.30(2) Rules - Examiner requisition 2001-02-15
Inactive: Application prosecuted on TS as of Log entry date 1999-05-06
Inactive: RFE acknowledged - Prior art enquiry 1999-05-06
Inactive: Status info is complete as of Log entry date 1999-05-06
Inactive: Entity size changed 1999-05-06
Request for Examination Requirements Determined Compliant 1999-04-20
All Requirements for Examination Determined Compliant 1999-04-20
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 1997-04-24
Inactive: Adhoc Request Documented 1997-04-24
Application Published (Open to Public Inspection) 1992-11-12

Abandonment History

Abandonment Date Reason Reinstatement Date
2002-09-11
1997-04-24

Maintenance Fee

The last payment was received on 2003-04-24

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
MF (application, 6th anniv.) - standard 06 1998-04-24 1998-04-23
MF (application, 7th anniv.) - small 07 1999-04-26 1999-04-20
Request for examination - small 1999-04-20
MF (application, 8th anniv.) - small 08 2000-04-25 2000-04-18
MF (application, 9th anniv.) - small 09 2001-04-24 2001-04-23
MF (application, 10th anniv.) - standard 10 2002-04-24 2002-04-24
Reinstatement 2002-09-11
MF (application, 11th anniv.) - standard 11 2003-04-24 2003-04-24
Final fee - standard 2003-04-25
MF (patent, 12th anniv.) - standard 2004-04-26 2004-04-19
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
MMTC INC.
NORTH SHORE UNIVERSITY HOSPITAL RESEARCH CORPORATION
Past Owners on Record
FRED STERZER
PAUL T. FINGER
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 2003-06-11 1 50
Claims 2001-06-15 3 113
Claims 2001-07-13 5 179
Claims 2002-01-04 5 186
Claims 2002-09-11 3 111
Cover Page 1998-07-13 1 17
Abstract 1993-03-24 1 53
Cover Page 1993-03-24 1 17
Description 1993-03-24 6 305
Claims 1993-03-24 4 157
Drawings 1993-03-24 4 52
Representative drawing 2002-10-03 1 10
Representative drawing 1998-08-04 1 5
Reminder - Request for Examination 1998-12-29 1 116
Acknowledgement of Request for Examination 1999-05-06 1 174
Notice of Reinstatement 2002-09-20 1 171
Courtesy - Abandonment Letter (R30(2)) 2002-09-16 1 170
Commissioner's Notice - Application Found Allowable 2002-10-25 1 163
Maintenance Fee Notice 2005-06-20 1 172
Correspondence 2003-04-25 1 34
Fees 2003-04-24 1 36
Correspondence 2001-04-23 1 41
PCT 1993-03-24 2 80
Correspondence 2000-04-18 1 32
Fees 2002-04-24 1 37
PCT 1993-03-24 2 74
Fees 1995-11-24 3 126
Fees 1999-04-20 1 39
Fees 1996-04-12 1 41
Fees 1995-01-19 1 48
Fees 1997-04-18 1 47
Fees 1994-04-15 1 35